Comparison of glucagon stimulation test and low dose ACTH test in assessing hypothalamic-pituitary-adrenal (HPA) axis in children.

Guy YalovitskyDavid ShakiEli HershkovitzMichael FrigerAlon Haim

Published in: Clinical endocrinology (2023)

The results of this study show that GST is not an optimal tool for diagnosing secondary AI. Therefore, clinicians using this test should interpret its results with caution.

Keyphrases

low dose
young adults
artificial intelligence
palliative care
high dose
growth hormone